These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7804135)

  • 21. Control of apolipoprotein E secretion in the human hepatoma cell line KYN-2.
    Brahimi F; Bertrand P; Starck M; Galteau MM; Siest G
    Cell Biochem Funct; 2001 Mar; 19(1):51-8. PubMed ID: 11223871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas.
    Dragović T; Deddish PA; Tan F; Weber G; Erdös EG
    Lab Invest; 1994 Jan; 70(1):107-13. PubMed ID: 8302012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The selective reduction in PTPdelta expression in hepatomas.
    Urushibara N; Karasaki H; Nakamura K; Mizuno Y; Ogawa K; Kikuchi K
    Int J Oncol; 1998 Mar; 12(3):603-7. PubMed ID: 9472099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-induced apoptosis in hepatoblastoma HepG2 cell line.
    Zhang J; Cheng C; He CL; Zhou YJ; Cao Y
    Cancer Invest; 2008 Jun; 26(5):456-63. PubMed ID: 18568767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
    Vucenik I; Tantivejkul K; Zhang ZS; Cole KE; Saied I; Shamsuddin AM
    Anticancer Res; 1998; 18(6A):4083-90. PubMed ID: 9891449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells.
    Kullak-Ublick GA; Beuers U; Paumgartner G
    Hepatology; 1996 May; 23(5):1053-60. PubMed ID: 8621133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silybin and dehydrosilybin inhibit cytochrome P450 1A1 catalytic activity: a study in human keratinocytes and human hepatoma cells.
    Dvorák Z; Vrzal R; Ulrichová J
    Cell Biol Toxicol; 2006 Mar; 22(2):81-90. PubMed ID: 16528449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
    Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
    Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human hepatoma cell telomerase activity inhibition and cell cycle modulation by its RNA component antisense oligodeoxyribonucleotides.
    Zhang RG; Wang XW; Yuan JH; Xie H
    Acta Pharmacol Sin; 2000 Aug; 21(8):742-6. PubMed ID: 11501185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketoconazole potentiates terfenadine-induced apoptosis in human Hep G2 cells through inhibition of cytochrome p450 3A4 activity.
    Wang YJ; Yu CF; Chen LC; Chen CH; Lin JK; Liang YC; Lin CH; Lin SY; Chen CF; Ho YS
    J Cell Biochem; 2002; 87(2):147-59. PubMed ID: 12244568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
    Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
    Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice.
    Schnater JM; Bruder E; Bertschin S; Woodtli T; de Theije C; Pietsch T; Aronson DC; von Schweinitz D; Lamers WH; Köhler ES
    J Hepatol; 2006 Sep; 45(3):377-86. PubMed ID: 16780998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5'-Nucleotide phosphodiesterase isoenzyme pattern in the serum of human hepatoma.
    Tsou KC; Ledis S; McCoy MG
    Cancer Res; 1973 Oct; 33(10):2215-7. PubMed ID: 4355019
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties.
    Wilkening S; Stahl F; Bader A
    Drug Metab Dispos; 2003 Aug; 31(8):1035-42. PubMed ID: 12867492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1,25-dihydroxyvitamin D3 dissolved in lipiodol produces a sustained antiproliferative effect in the human hepatoblastoma cell line HepG2.
    Pourgholami MH; Akhter J; Finlay IG; Morris DL
    Anticancer Res; 2000; 20(2A):723-7. PubMed ID: 10810346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate.
    Duclos S; Bride J; Ramirez LC; Bournot P
    Eur J Cell Biol; 1997 Apr; 72(4):314-23. PubMed ID: 9127731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gamma-glutamyltransferase from human hepatoma cell lines: purification and cell culture of HepG2 on microcarriers.
    Visvikis A; Goergen JL; Oster T; Bagrel D; Wellman M; Marc A; Engasser JM; Siest G
    Clin Chim Acta; 1990 Nov; 191(3):221-32. PubMed ID: 1979762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical protein regulation of adenylate kinases from muscle, liver, and hepatoma.
    Criss WE; Pradhan TK; Morris HP
    Cancer Res; 1974 Nov; 34(11):3062-5. PubMed ID: 4371080
    [No Abstract]   [Full Text] [Related]  

  • 39. Demonstration that the enzyme that converts precursor of apolipoprotein A-I to apolipoprotein A-I is secreted by the hepatocarcinoma cell line Hep G2.
    Edelstein C; Kaiser M; Piras G; Scanu AM
    Arch Biochem Biophys; 1988 Nov; 267(1):23-30. PubMed ID: 2848450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of poly (C) avid serum ribonuclease in hepatoma patients.
    Francesconi M; Meryn S
    Cancer Detect Prev; 1987; 10(5-6):379-81. PubMed ID: 3032438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.